VEON vs. UAMY

Last updated Apr 2, 2026

Compare and contrast key facts about VEON Ltd. (VEON) and United States Antimony Corporation (UAMY).

Performance

VEON vs. UAMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VEON Ltd. (VEON) and United States Antimony Corporation (UAMY). The values are adjusted to include any dividend payments, if applicable.

VEON vs. UAMY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VEON VEON Ltd.	-10.06%	31.10%	103.55%	60.82%	-71.35%	13.25%	-37.09%	18.88%	-34.17%	5.59%
UAMY United States Antimony Corporation	65.34%	183.62%	610.84%	-48.86%	-2.19%	-4.64%	35.58%	-33.62%	81.25%	27.49%

Fundamentals

Market Cap VEON : $2.50B UAMY : $1.03B
EPS VEON : $8.32 UAMY : -$0.03
PS Ratio VEON : 0.68 UAMY : 26.38
PB Ratio VEON : 1.87 UAMY : 7.28
Total Revenue (TTM) VEON : $4.41B UAMY : $39.26M
Gross Profit (TTM) VEON : $3.68B UAMY : $9.87M
EBITDA (TTM) VEON : $1.61B UAMY : -$6.89M

Returns By Period

In the year-to-date period, VEON achieves a -10.06% return, which is significantly lower than UAMY's 65.34% return. Over the past 10 years, VEON has underperformed UAMY with an annualized return of -5.00%, while UAMY has yielded a comparatively higher 42.52% annualized return.

VEON

• 1D: 2.12%
• 1M: -15.63%
• YTD: -10.06%
• 6M: -10.45%
• 1Y: 7.07%
• 3Y*: 38.70%
• 5Y*: 1.45%
• 10Y*: -5.00%

UAMY

• 1D: -4.93%
• 1M: -22.07%
• YTD: 65.34%
• 6M: 9.93%
• 1Y: 268.89%
• 3Y*: 180.17%
• 5Y*: 47.47%
• 10Y*: 42.52%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

VEON vs. UAMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VEON

VEON Risk / Return Rank: 45
VEON Sharpe Ratio Rank: 45
VEON Sortino Ratio Rank: 44
VEON Omega Ratio Rank: 44
VEON Calmar Ratio Rank: 48
VEON Martin Ratio Rank: 47

UAMY

UAMY Risk / Return Rank: 86
UAMY Sharpe Ratio Rank: 90
UAMY Sortino Ratio Rank: 88
UAMY Omega Ratio Rank: 82
UAMY Calmar Ratio Rank: 89
UAMY Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VEON vs. UAMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VEON Ltd. (VEON) and United States Antimony Corporation (UAMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	VEON	UAMY	Difference
Sharpe ratio Return per unit of total volatility	0.12	2.06	-1.94
Sortino ratio Return per unit of downside risk	0.60	2.71	-2.11
Omega ratio Gain probability vs. loss probability	1.08	1.31	-0.23
Calmar ratio Return relative to maximum drawdown	0.26	3.73	-3.47
Martin ratio Return relative to average drawdown	0.54	6.95	-6.41
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

VEON vs. UAMY - Sharpe Ratio Comparison

The current VEON Sharpe Ratio is 0.12, which is lower than the UAMY Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of VEON and UAMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	VEON	UAMY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.12	2.06	-1.94
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.02	0.51	-0.49
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.09	0.43	-0.51
Sharpe Ratio (All Time) Calculated using the full available price history	0.04	0.07	-0.03

Correlation

The correlation between VEON and UAMY is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

VEON vs. UAMY - Dividend Comparison

Neither VEON nor UAMY has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
VEON VEON Ltd.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.62%	9.58%	9.47%	5.97%	0.68%	0.80%
UAMY United States Antimony Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

VEON vs. UAMY - Drawdown Comparison

The maximum VEON drawdown since its inception was -98.74%, roughly equal to the maximum UAMY drawdown of -96.44%. Use the drawdown chart below to compare losses from any high point for VEON and UAMY.

Drawdown Indicators

	VEON	UAMY	Difference
Max Drawdown Largest peak-to-trough decline	-98.74%	-96.44%	-2.30%
Max Drawdown (1Y) Largest decline over 1 year	-32.15%	-74.30%	+42.15%
Max Drawdown (5Y) Largest decline over 5 years	-88.66%	-84.49%	-4.17%
Max Drawdown (10Y) Largest decline over 10 years	-92.52%	-89.76%	-2.76%
Current Drawdown Current decline from peak	-90.95%	-52.49%	-38.46%
Average Drawdown Average peak-to-trough decline	-62.42%	-66.57%	+4.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.73%	39.90%	-24.17%

Volatility

VEON vs. UAMY - Volatility Comparison

The current volatility for VEON Ltd. (VEON) is 25.16%, while United States Antimony Corporation (UAMY) has a volatility of 39.33%. This indicates that VEON experiences smaller price fluctuations and is considered to be less risky than UAMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VEON	UAMY	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.16%	39.33%	-14.17%
Volatility (6M) Calculated over the trailing 6-month period	36.13%	107.41%	-71.28%
Volatility (1Y) Calculated over the trailing 1-year period	58.14%	131.56%	-73.42%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	68.87%	93.61%	-24.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	55.90%	100.36%	-44.46%

Financials

VEON vs. UAMY - Profitability Comparison

The chart below illustrates the profitability comparison between VEON Ltd. and United States Antimony Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

VEON - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, VEON Ltd. reported a gross profit of 815.31M and revenue of 1.18B. Therefore, the gross margin over that period was 68.9%.

UAMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported a gross profit of 2.65M and revenue of 13.03M. Therefore, the gross margin over that period was 20.3%.

VEON - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, VEON Ltd. reported an operating income of 319.26M and revenue of 1.18B, resulting in an operating margin of 27.0%.

UAMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported an operating income of -3.92M and revenue of 13.03M, resulting in an operating margin of -30.1%.

VEON - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, VEON Ltd. reported a net income of -31.32M and revenue of 1.18B, resulting in a net margin of -2.7%.

UAMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported a net income of -286.91K and revenue of 13.03M, resulting in a net margin of -2.2%.